UniProt ID | RYBP_HUMAN | |
---|---|---|
UniProt AC | Q8N488 | |
Protein Name | RING1 and YY1-binding protein | |
Gene Name | RYBP | |
Organism | Homo sapiens (Human). | |
Sequence Length | 228 | |
Subcellular Localization | Nucleus . Cytoplasm . Nucleus, nucleoplasm . Primarily found in the nucleus. Detected in a punctate pattern likely to represent Polycomb group (PcG) bodies (By similarity). | |
Protein Description | Component of a Polycomb group (PcG) multiprotein PRC1-like complex, a complex class required to maintain the transcriptionally repressive state of many genes, including Hox genes, throughout development. PcG PRC1-like complex acts via chromatin remodeling and modification of histones; it mediates monoubiquitination of histone H2A 'Lys-119', rendering chromatin heritably changed in its expressibility. [PubMed: 25519132 Component of a PRC1-like complex that mediates monoubiquitination of histone H2A 'Lys-119' on the X chromosome and is required for normal silencing of one copy of the X chromosome in XX females. May stimulate ubiquitination of histone H2A 'Lys-119' by recruiting the complex to target sites (By similarity Inhibits ubiquitination and subsequent degradation of TP53, and thereby plays a role in regulating transcription of TP53 target genes] | |
Protein Sequence | MTMGDKKSPTRPKRQAKPAADEGFWDCSVCTFRNSAEAFKCSICDVRKGTSTRKPRINSQLVAQQVAQQYATPPPPKKEKKEKVEKQDKEKPEKDKEISPSVTKKNTNKKTKPKSDILKDPPSEANSIQSANATTKTSETNHTSRPRLKNVDRSTAQQLAVTVGNVTVIITDFKEKTRSSSTSSSTVTSSAGSEQQNQSSSGSESTDKGSSRSSTPKGDMSAVNDESF | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
8 | Phosphorylation | MTMGDKKSPTRPKRQ CCCCCCCCCCCCCCC | 36.93 | 17081983 | |
10 | Phosphorylation | MGDKKSPTRPKRQAK CCCCCCCCCCCCCCC | 67.69 | 20068231 | |
17 | Ubiquitination | TRPKRQAKPAADEGF CCCCCCCCCCCCCCC | 27.18 | 32015554 | |
40 | Methylation | RNSAEAFKCSICDVR ECCCHHHCCEECCCC | 33.83 | 115977433 | |
40 | Ubiquitination | RNSAEAFKCSICDVR ECCCHHHCCEECCCC | 33.83 | 33845483 | |
59 | Phosphorylation | TRKPRINSQLVAQQV CCCCCCCHHHHHHHH | 23.63 | 26055452 | |
70 | Phosphorylation | AQQVAQQYATPPPPK HHHHHHHHCCCCCCC | 10.60 | 28796482 | |
72 | Phosphorylation | QVAQQYATPPPPKKE HHHHHHCCCCCCCHH | 31.24 | 25159151 | |
77 | Sumoylation | YATPPPPKKEKKEKV HCCCCCCCHHHHHHH | 78.37 | 28112733 | |
99 | Phosphorylation | PEKDKEISPSVTKKN CCCCCCCCCCCCCCC | 16.53 | 29255136 | |
101 | Phosphorylation | KDKEISPSVTKKNTN CCCCCCCCCCCCCCC | 35.31 | 30266825 | |
103 | Phosphorylation | KEISPSVTKKNTNKK CCCCCCCCCCCCCCC | 40.41 | 22167270 | |
104 | Acetylation | EISPSVTKKNTNKKT CCCCCCCCCCCCCCC | 41.70 | 25953088 | |
104 | Ubiquitination | EISPSVTKKNTNKKT CCCCCCCCCCCCCCC | 41.70 | 32015554 | |
107 | Phosphorylation | PSVTKKNTNKKTKPK CCCCCCCCCCCCCCH | 58.24 | - | |
114 | Ubiquitination | TNKKTKPKSDILKDP CCCCCCCHHHHHCCC | 63.42 | 23000965 | |
115 | Phosphorylation | NKKTKPKSDILKDPP CCCCCCHHHHHCCCH | 38.11 | 25159151 | |
119 | Ubiquitination | KPKSDILKDPPSEAN CCHHHHHCCCHHHHH | 69.40 | 23000965 | |
123 | Phosphorylation | DILKDPPSEANSIQS HHHCCCHHHHHHHHH | 55.52 | 30266825 | |
127 | Phosphorylation | DPPSEANSIQSANAT CCHHHHHHHHHCCCC | 29.11 | 23401153 | |
130 | Phosphorylation | SEANSIQSANATTKT HHHHHHHHCCCCCCC | 23.09 | 23401153 | |
134 | Phosphorylation | SIQSANATTKTSETN HHHHCCCCCCCCCCC | 28.74 | 22199227 | |
135 | Phosphorylation | IQSANATTKTSETNH HHHCCCCCCCCCCCC | 29.89 | 22199227 | |
136 | Ubiquitination | QSANATTKTSETNHT HHCCCCCCCCCCCCC | 45.78 | 21906983 | |
154 | Phosphorylation | RLKNVDRSTAQQLAV CCCCCCHHHHHHHHH | 24.51 | 20068231 | |
155 | Phosphorylation | LKNVDRSTAQQLAVT CCCCCHHHHHHHHHE | 29.40 | 20068231 | |
162 | Phosphorylation | TAQQLAVTVGNVTVI HHHHHHHEECCEEEE | 19.65 | 20068231 | |
167 | Phosphorylation | AVTVGNVTVIITDFK HHEECCEEEEEECCC | 15.24 | 20068231 | |
171 | Phosphorylation | GNVTVIITDFKEKTR CCEEEEEECCCHHHC | 25.02 | 20068231 | |
177 | Phosphorylation | ITDFKEKTRSSSTSS EECCCHHHCCCCCCC | 36.55 | 28450419 | |
179 | Phosphorylation | DFKEKTRSSSTSSST CCCHHHCCCCCCCCE | 33.59 | 25159151 | |
180 | Phosphorylation | FKEKTRSSSTSSSTV CCHHHCCCCCCCCEE | 34.05 | 28450419 | |
181 | Phosphorylation | KEKTRSSSTSSSTVT CHHHCCCCCCCCEEE | 33.29 | 30206219 | |
182 | Phosphorylation | EKTRSSSTSSSTVTS HHHCCCCCCCCEEEC | 34.28 | 28450419 | |
183 | Phosphorylation | KTRSSSTSSSTVTSS HHCCCCCCCCEEECC | 25.00 | 30206219 | |
184 | Phosphorylation | TRSSSTSSSTVTSSA HCCCCCCCCEEECCC | 30.07 | 28450419 | |
185 | Phosphorylation | RSSSTSSSTVTSSAG CCCCCCCCEEECCCC | 27.02 | 28450419 | |
186 | Phosphorylation | SSSTSSSTVTSSAGS CCCCCCCEEECCCCC | 29.74 | 25262027 | |
188 | Phosphorylation | STSSSTVTSSAGSEQ CCCCCEEECCCCCCC | 19.63 | 30206219 | |
189 | Phosphorylation | TSSSTVTSSAGSEQQ CCCCEEECCCCCCCC | 17.54 | 28450419 | |
190 | Phosphorylation | SSSTVTSSAGSEQQN CCCEEECCCCCCCCC | 27.55 | 28450419 | |
193 | Phosphorylation | TVTSSAGSEQQNQSS EEECCCCCCCCCCCC | 31.76 | 28450419 | |
199 | Phosphorylation | GSEQQNQSSSGSEST CCCCCCCCCCCCCCC | 33.74 | 25159151 | |
200 | Phosphorylation | SEQQNQSSSGSESTD CCCCCCCCCCCCCCC | 29.02 | 25262027 | |
201 | Phosphorylation | EQQNQSSSGSESTDK CCCCCCCCCCCCCCC | 52.14 | 25262027 | |
203 | Phosphorylation | QNQSSSGSESTDKGS CCCCCCCCCCCCCCC | 30.26 | 28450419 | |
205 | Phosphorylation | QSSSGSESTDKGSSR CCCCCCCCCCCCCCC | 43.53 | 28450419 | |
206 | Phosphorylation | SSSGSESTDKGSSRS CCCCCCCCCCCCCCC | 37.36 | 28450419 | |
208 | Ubiquitination | SGSESTDKGSSRSST CCCCCCCCCCCCCCC | 61.86 | - | |
210 | Phosphorylation | SESTDKGSSRSSTPK CCCCCCCCCCCCCCC | 28.46 | 28102081 | |
211 | Phosphorylation | ESTDKGSSRSSTPKG CCCCCCCCCCCCCCC | 44.87 | 28102081 | |
213 | Phosphorylation | TDKGSSRSSTPKGDM CCCCCCCCCCCCCCC | 40.28 | 22617229 | |
214 | Phosphorylation | DKGSSRSSTPKGDMS CCCCCCCCCCCCCCC | 47.85 | 25159151 | |
215 | Phosphorylation | KGSSRSSTPKGDMSA CCCCCCCCCCCCCCC | 30.21 | 25159151 | |
221 | Phosphorylation | STPKGDMSAVNDESF CCCCCCCCCCCCCCC | 33.53 | 22115753 | |
227 | Phosphorylation | MSAVNDESF------ CCCCCCCCC------ | 38.84 | 25159151 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RYBP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RYBP_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127; SER-130 ANDSER-227, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-99 AND SER-127, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-127 AND SER-130, ANDMASS SPECTROMETRY. |